Armstrong Advisory Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.7K Hold
368
﹤0.01% 514
2026
Q1
$33.3K Sell
368
-40
-10% -$3.67K ﹤0.01% 479
2025
Q4
$36.7K Buy
408
+1
+0.2% +$95 ﹤0.01% 447
2025
Q3
$40.1K Hold
407
﹤0.01% 433
2025
Q2
$37.1K Hold
407
﹤0.01% 432
2025
Q1
$43K Hold
407
﹤0.01% 388
2024
Q4
$43K Buy
407
+1
+0.2% +$107 ﹤0.01% 388
2024
Q3
$43.9K Sell
406
-40
-9% -$4.37K ﹤0.01% 386
2024
Q2
$48.4K Hold
446
﹤0.01% 362
2024
Q1
$54.3K Hold
446
0.01% 334
2023
Q4
$54.3K Hold
446
0.01% 334
2023
Q3
$50K Buy
446
+1
+0.2% +$127 0.01% 334
2023
Q2
$64.8K Sell
445
-8
-2% -$1.09K 0.01% 306
2023
Q1
$58.6K Hold
453
0.01% 302
2022
Q4
$57.8K Buy
+453
New +$52.6K 0.01% 301

Other funds holding ZBH

Armstrong Advisory Group's ZBH Position: Q2 2026 in Review

Armstrong Advisory Group held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 368 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Armstrong Advisory Group first reported a position in ZBH in Q4 2022 and has held it in 15 quarters since. The position peaked at $64.8K in Q2 2023. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Armstrong Advisory Group held 368 shares of Zimmer Biomet worth $31.7K as of Q2 2026.
  • Armstrong Advisory Group left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #514 holding.
  • Armstrong Advisory Group first reported a position in Zimmer Biomet in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Zimmer Biomet position peaked at $64.8K in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.